Medical device company NuVasive will acquire Biotronic NeuroNetwork for $98 million.
Supply Chain
Minneapolis-based Medtronic, the world's largest standalone medical device manufacturer, is developing a new robotic surgical system expected to be released by 2019.
In response to the growing amount of opioid overdoses in the last decade, health officials have placed stronger restrictions on access to the drugs, posing a problem to the large elderly population that relies on opioids for chronic pain relief,…
Liquid biopsies, which detect fragments of tumor DNA in the bloodstream, may be an effective alternative to conventional tumor biopsies, according to The New York Times.
Atlanta-based medical device developer Vertera Spine announced the first implantations of their Cohere Cervical Fusion Device, which features the company's patented porous biomaterial technology.
Last week, researchers at Rabin Medical Center in Petah-Tikvah, Israel, presented a study of cancer drug prices in seven countries at the American Society of Clinical Oncology's annual meeting in Chicago.
A combination of two chemotherapy drugs show promising results in fighting pancreatic cancer, according to a study presented at the American Society of Clinical Oncology's annual meeting Friday.
A newly approved drug that boosts the immune system helps stall the spread of tumors in patients with advanced bladder cancer.
John Lewandowski, a PhD student in mechanical engineering at MIT, created a medical device that can detect malaria in five seconds from a drop of blood.
Healthcare supply chains struggle with waste and inefficiency. However, radio-frequency identification technology is changing the game by enabling automated stocking, accurate usage capture, healthcare ecosystem compatibility and robust data analytics.